News

Researchers led by our SPARKee Ulrike Stein of the ECRC and Robert Preißner of Charité report in "Clinical and Translational Medicine" that statins inhibit a gene that promotes cancer cell metastasis.

NeuroCure grants funding extension to the four NeuroCure/SPARK-BIH teams for an additional year.

A warm welcome to the newest member of the SPARK global community. SPARK the Midlands (Birmingham,…

The second edition of "A Practical Guide to Drug Development in Academia: The SPARK Approach“ written by the founders of SPARK in SPARK Stanford Prof. Daria Mochly-Rosen and Prof. Kevin Grimes is published.

Congratulations to Gabriele Pecher and her team for receiving the price for the best contribution!

Three SPARK Teams presented their innovative projects at the Cooperation & Venture Track.

The sessions are open to the entire SPARK network and welcome anyone with an interest in GCT and associated diagnostics – join us to connect, learn, and shape the future of advanced therapies!

The German Research Foundation (DFG) has awarded Prof. Dr. Volker Haucke the prestigious Gottfried Wilhelm Leibniz Prize 2025.

Congratulations to Dr. Marco Zierhut, SPARKee, Fellow of the BIH Charité Clinician Scientist Program (CSP) and Senior Physician at the Department of Psychiatry and Psychotherapy at the Charité (Campus Benjamin Franklin).

SPARK-BIH is very pleased to announce the official launch of the 2nd Germany-Wide Call for Translational Projects in Gene and Cell-Based Therapies and Associated Diagnostics in collaboration with DLR.